JD

Jennie Daisak

Vice President at Bain Capital Life Sciences

New York City Metropolitan Area

Invests in

Locations:

  • Min Investment:

    $100,000.00
  • Max Investment:

    $5,000,000.00
  • Target Investment:

    $1,500,000.00

Education

  • Bachelor of Science (B.S.) in Applied Economics, Finance Concentration, Summa cum laude

    (2015 - 2019)

  • Bachelor of Arts (B.A.) in Biology, Summa cum laude

    University of Pennsylvania

    (2015 - 2019)

  • The Lawrenceville School

    (2010 - 2015)

Work Experience

  • Vice President

    2024

  • Associate

    2021 - 2024

  • Healthcare Investment Banking Analyst

    2019 - 2021

  • Healthcare Investment Banking Summer Analyst

    2018 - 2018

  • Clinical Research Assistant

    2016 - 2018

    • Clinical Research Assistant for Dr. Susan Rheingold, an attending physician studying relapsed leukemia at CHOP. • Retrieved and analyzed data to investigate the clinical significance of a novel gene fusion in pediatric patients.

  • Lead Discovery and Optimization Intern

    2017 - 2017

    • Identified new small molecule targets for combination immuno-oncology treatments using gene profiling in fulfillment of the Life Sciences and Management Program’s required scientific research internship. • Performed statistical analysis on data sets with over ten thousand data points and presented findings to BMS leadership. • Gained insight into BMS business model through exposure to several business areas and top executives.

  • Research Assistant

    2014 - 2014

    • Performed experiments and analyzed data to explore the tumor suppressive functions of the urea cycle in renal cell carcinoma in the lab of Dr. Celeste Simon • Co-authored a paper published in Cell Metabolism: Ochocki et al., Arginase 2 Suppresses Renal Carcinoma Progression via Biosynthetic Cofactor Pyridoxal Phosphate Depletion and Increased Polyamine Toxicity, Cell Metabolism (2018), https://doi.org/10.1016/j.cmet.2018.04.009